APA

Janssens R., Mortier A., Boff D., Ruytinx P., Gouwy M., Vantilt B., Larsen O., Daugvilaite V., Rosenkilde M. M., Parmentier M., Noppen S., Liekens S., Van Damme J., Struyf S., Teixeira M. M., Amaral F. A. & Proost P. (20170515). Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes. : Biochemical pharmacology.

Chicago

Janssens Rik, Mortier Anneleen, Boff Daiane, Ruytinx Pieter, Gouwy Mieke, Vantilt Bo, Larsen Olav, Daugvilaite Viktorija, Rosenkilde Mette M, Parmentier Marc, Noppen Sam, Liekens Sandra, Van Damme Jo, Struyf Sofie, Teixeira Mauro M, Amaral Flávio A and Proost Paul. 20170515. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes. : Biochemical pharmacology.

Harvard

Janssens R., Mortier A., Boff D., Ruytinx P., Gouwy M., Vantilt B., Larsen O., Daugvilaite V., Rosenkilde M. M., Parmentier M., Noppen S., Liekens S., Van Damme J., Struyf S., Teixeira M. M., Amaral F. A. and Proost P. (20170515). Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes. : Biochemical pharmacology.

MLA

Janssens Rik, Mortier Anneleen, Boff Daiane, Ruytinx Pieter, Gouwy Mieke, Vantilt Bo, Larsen Olav, Daugvilaite Viktorija, Rosenkilde Mette M, Parmentier Marc, Noppen Sam, Liekens Sandra, Van Damme Jo, Struyf Sofie, Teixeira Mauro M, Amaral Flávio A and Proost Paul. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes. : Biochemical pharmacology. 20170515.